— Shares of the online brokerage fell 2.4% after reporting disappointing 2019 Q2 earnings. The company's second quarter earnings-per-share were 46 cents. Analysts polled by Refinitiv expected a profit of 53 cents per share. The company's results were impacted by lower trading commissions and an 8% rise in expenses.
— Seattle Genetics rose over 18% as investors cheered record sales of Adcetris, a drug used to treat Hodgkin's lymphoma. The company said Adcetris generated $159 million in U.S. and Canada sales. The Adcetris overshadowed mixed quarterly results. Piper Jaffray raised the company's stock to overweight from neutral, citing the drug's strong performance.
When global policy is unclear and unstable, business decision making will be affected. Uncertain disruption dies have marketplace impact. This important issue for leadership and management
대한민국 최근 뉴스, 대한민국 헤드 라인
Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.
Stocks making the biggest moves premarket: Bank of America, United Airlines, Amazon, CSX & moreThese are the stocks posting the largest moves before the bell. For CSX and the rails the honeymoon from the PSR fraud is over.
더 많은 것을 읽으십시오 »
CSX stock falls after earnings missCSX Corp. shares dropped in the extended session Tuesday after the railroad operator's quarterly results fell short of Wall Street estimates. CSX shares fell...
더 많은 것을 읽으십시오 »
Stocks making the biggest moves midday: JB Hunt, Domino's Pizza, Wells Fargo & moreThese are the stocks posting the largest moves midday.
더 많은 것을 읽으십시오 »
S&P trades near flat as Citigroup results weigh on bank stocksThe benchmark S&P 500 index struggled for direction in choppy trade on Monday as... This picture is overused! They can kiss our butts for a bailout this time,..
더 많은 것을 읽으십시오 »